Complications after ERCP in liver transplant recipients

Gastrointestinal Endoscopy

Volumn 74, Issue 2, 2011, Pages 285-294

  Balderramo, Domingo ^a   Bordas, Josep M ^a   Sendino, Oriol ^a   Abraldes, Juan G ^a   Navasa, Miguel ^a   Llach, Josep ^a   Cardenas, Andres ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

anastomotic stricture; AS; liver transplant; LT; mammalian target of rapamycin; mTOR; NAS; nonanastomotic stricture; odds ratio; OR; SOD; sphincter of Oddi dysfunction

Indexed keywords

CREATININE; CYCLOSPORIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ANASTOMOSIS; ARTICLE; BLEEDING; CHOLANGITIS; CREATININE BLOOD LEVEL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEMATOMA; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT; PANCREATITIS; PRIORITY JOURNAL; RISK FACTOR; SPHINCTEROTOMY; TREATMENT OUTCOME;

AGED; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CONTRAST MEDIA; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENGTH OF STAY; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATITIS; POSTOPERATIVE HEMORRHAGE; PREDNISOLONE; RETROSPECTIVE STUDIES; RISK FACTORS; SPHINCTEROTOMY, ENDOSCOPIC; TOR SERINE-THREONINE KINASES;

EID: 79960959374     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.04.025     Document Type: Article

References (45)

1. Thuluvath PJ, Pfau PR, Kimmey MB, et al. Biliary complications after liver transplantation: the role of endoscopy. Endoscopy 2005;37:857-63. (Pubitemid 41263961)
2. Safdar K, Atiq M, Stewart C, et al. Biliary tract complications after liver transplantation. Expert Rev Gastroenterol Hepatol 2009;3:183-95.
3. Ayoub WS, Esquivel CO, Martin P. Biliary complications following liver transplantation. Dig Dis Sci 2010;55:1540-6.
4. Krok K, Cárdenas A, Thuluvath PJ. Endoscopic management of biliary complications after liver transplantation. Clin Liver Dis 2010;14:359-71.
5. Sharma S, Gurakar A, Jabbour N. Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl 2008; 14:759-69. (Pubitemid 351895506)
6. Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002;55:224-31. (Pubitemid 41115186)
7. Pfau PR, Kochman ML, Lewis JD, et al. Endoscopic management of post-operative biliary complications in orthotopic liver transplantation. Gastrointest Endosc 2000;52:55-63. (Pubitemid 30469714)
8. Thuluvath PJ, Atassi T, Lee J. An endoscopic approach to biliary complications following orthotopic liver transplantation. Liver Int 2003;23:156-62. (Pubitemid 37265788)
9. They S, Thomson B, Pleass H, et al. Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant 2004;18:647-53. (Pubitemid 39496976)
10. Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009;70:80-8.
11. Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007;39:793-801. (Pubitemid 47386828)
12. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009;104:31-40.
13. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10. (Pubitemid 28337421)
14. Christensen M, Matzen P, Schulze S, et al. Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60:721-31. (Pubitemid 39550929)
15. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96:417-23.
16. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18. (Pubitemid 26314443)
17. Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56:652-6. (Pubitemid 36531698)
18. Gómez CM, Dumonceau JM, Marcolongo M, et al. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation 2009;88:1280-5.
19. Sanna C, Saracco GM, Reggio D, et al. Endoscopic retrograde cholangiopancreatography in patients with biliary complications after orthotopic liver transplantation: outcomes and complications. Transplant Proc 2009;41:1319-21.
20. Mata A, Bordas JM, Llach J, et al. ERCP in orthotopic liver transplanted patients. Hepatogastroenterology 2004;51:1801-4. (Pubitemid 39389784)
21. Morelli J, Mulcahy HE, Willner IR, et al. Long-term outcomes for patients with post-liver transplant anastomotic biliary strictures treated by endoscopic stent placement. Gastrointest Endosc 2003;58:374-9. (Pubitemid 38220236)
22. Holt AP, Thorburn D, Mirza D, et al. A prospective study of standardized nonsurgical therapy in the management of biliary anastomotic strictures complicating liver transplantation. Transplantation 2007;84:857-63. (Pubitemid 351338946)
23. Pasha SF, Harrison ME, Das A, et al. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2007;66:44-51. (Pubitemid 46962497)
24. Morelli G, Fazel A, Judah J, et al. Rapid-sequence endoscopic management of posttransplant anastomotic biliary strictures. Gastrointest Endosc 2008;67:879-85.
25. Tabibian JH, Asham EH, Goldstein L, et al. Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures. Gastrointest Endosc 2009;69:1236-43.
26. Tabibian JH, Asham EH, Han S, et al. Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video). Gastrointest Endosc 2010;71:505-12.
27. Barriga J, Thompson R, Shokouh-Amiri H, et al. Biliary strictures after liver transplantation. Predictive factors for response to endoscopic management and long-term outcome. Am J Med Sci 2008;335:439-43.
28. Weber A, Prinz C, Gerngross C, et al. Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation. J Gastroenterol 2009;44:1195-202.
29. Zoepf T, Maldonado-Lopez EJ, Hilgard P, et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl 2006;12:88-94.
30. Kulaksiz H, Weiss KH, Gotthardt D, et al. Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy 2008;40:746-51.
31. Seo JK, Ryu JK, Lee SH, et al. Endoscopic treatment for biliary stricture after adult living donor liver transplantation. Liver Transpl 2009;15:369-80.
32. Kato H, Kawamoto H, Tsutsumi K, et al. Long-term outcomes of endoscopic management for biliary strictures after living donor liver transplantation with duct-to-duct reconstruction. Transpl Int 2009;22:914-21.
33. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-93.
34. Cotton PB, Eisen GM, Aabakken L, et al.Alexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446-54.
35. Steyerberg EW, Harrell FE Jr, Borsboom GJ, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 2001;54:774-81. (Pubitemid 32722180)
36. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 2001;122:430-9. (Pubitemid 32843940)
37. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781-8. (Pubitemid 47206695)
38. Willems MC, van der Vliet JA, de Man BM, et al. Persistent effects of everolimus on strength of experimental wounds in intestine and fascia. Wound Repair Regen 2010;18:98-104.
39. Küper MA, Schölzl N, Traub F, et al. Everolimus interferes with the inflammatory phase of healing in experimental colonic anastomoses. J Surg Res 2011;167:158-65.
40. Smith AD, Bai D, Marroquin CE, et al. Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus. Clin Transplant 2005;19:250-4. (Pubitemid 40424898)
41. Dhar A, Patín, SS, Monahan KJ, et al. Incidence rates of post-ERCP complications: a case-control study in renal transplant recipients and dialysis patients [abstract]. Gastrointest Endosc 2010;71:AB161.
42. Bruno MJ, van Westerloo DJ, van Dorp WT, et al. Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology. Gut 2000;46:385-9. (Pubitemid 30313391)
43. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010;42:503-15.
44. Zheng M, Bai J, Yuan B, et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol 2008;Feb 14;8:6.
45. Bai Y, Gao J, Shi X, et al. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology 2008;8:504-9.